6 (1 Methyl 1 H Pyrazol 4 Yl) 3 (2 Methyl 2 H Indazol 5 Ylthio)

6 (1 Methyl 1 H Pyrazol 4 Yl) 3 (2 Methyl 2 H Indazol 5 Ylthio) [1,2,4] Triazolo [4,3 B] Pyridazine As A C Met Inhibitor

Abstract: The present invention relates to a c-Met inhibitor (disclosed herein) or a pharmaceutically acceptable salt thereof useful in treating cancer mediated by activity of c-Met receptors.

Patent Information

Application #

Filing Date

31 December 2012

Publication Number

24/2015

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate Center City of Indianapolis State of Indiana 46285 United States of America.

Inventors

1. WU Zhipei

c/o. Eli Lilly and Company P. O. Box 6288 Indianapolis Indiana 46206-6288 U.S.A.

Specification

PLEASE SEE THE SPECIFICATION ATTACHED

Documents

Application Documents

#	Name	Date
1	2924-MUMNP-2012-OTHER DOCUMENT(8-1-2013).pdf	2018-08-11
2	2924-MUMNP-2012-FORM PCT-ISA-237(26-2-2013).pdf	2018-08-11
3	2924-MUMNP-2012-FORM PCT-IB-326(26-2-2013).pdf	2018-08-11
4	2924-MUMNP-2012-FORM 3(26-6-2013).pdf	2018-08-11
5	2924-MUMNP-2012-FORM 26(7-5-2013).pdf	2018-08-11
6	2924-MUMNP-2012-FORM 18(8-1-2013).pdf	2018-08-11
7	2924-MUMNP-2012-FORM 13(7-5-2013).pdf	2018-08-11
8	2924-MUMNP-2012-FER.pdf	2018-08-11
9	2924-MUMNP-2012-ENGLISH TRANSLATION(15-1-2013).pdf	2018-08-11
10	2924-MUMNP-2012-CORRESPONDENCE(8-1-2013).pdf	2018-08-11
11	2924-MUMNP-2012-CORRESPONDENCE(7-5-2013).pdf	2018-08-11
12	2924-MUMNP-2012-CORRESPONDENCE(26-6-2013).pdf	2018-08-11
13	2924-MUMNP-2012-CORRESPONDENCE(26-2-2013).pdf	2018-08-11
14	2924-MUMNP-2012-CORRESPONDENCE(15-1-2013).pdf	2018-08-11
15	2924-MUMNP-2012-CLAIMS(AMENDED)-(7-5-2013).pdf	2018-08-11
16	2924-MUMNP-2012-ASSIGNMENT(8-1-2013).pdf	2018-08-11
17	2924-MUMNP-2012-AbandonedLetter.pdf	2018-08-11

Search Strategy

1	Bicyclictriazolesandcancer_24-08-2017.pdf